Remove 2030 Remove Drug Pricing Remove Pharmaceutical Manufacturing
article thumbnail

As Trump Pharma Tariff Deadline Looms, Here's How the Sector Got Here

Pharmaceutical Commerce

Tariffs on China will make generic drug prices go up I assume because China is such an important supplier of active pharmaceutical ingredients, as well as finished products.” 18 – The US announces it plans to improve a tariff of 25% or higher on pharmaceuticals. Pharmaceutical Commerce. Pharmaceutical Commerce.

article thumbnail

United States, European Union Reach Trade Pact

Pharmaceutical Commerce

Key Takeaways A formal trade agreement between the US and EU introduces a 15% tariff on most EU exports, including pharmaceuticals, potentially costing the pharma sector $13 billion–$19 billion. Experts recommend stockpiling medications and using forecasting tools to navigate tariff uncertainty and mitigate potential supply disruptions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca Commits $50 Billion to US Manufacturing and R&D Efforts by 2030

Pharmaceutical Commerce

AstraZeneca will be investing $50 billion in the United States by the year 2030. billion announced in November of last year, 1 it will be investing $50 billion in the United States by the year 2030. billion announced in November of last year, 1 it will be investing $50 billion in the United States by the year 2030.

article thumbnail

STAT+: Pharmalittle: We’re reading about Roche and Sanofi reactions to Trump, R&D rankings, and more

STAT

… Roche warned that President Trump’s executive order on drug pricing threatens its planned $50 billion investment in the United States , Reuters writes. The order directs drugmakers to lower prices of brand-name medicines to align with those in other wealthy nations. Best of luck, everyone.